Data illustrated increased odds of metabolic burden in adults newly diagnosed with psoriatic arthritis.

Less than 20% of women with hypertension or diabetes during pregnancy are screened for diabetes and dyslipidemia post partum, research indicates.

A healthy plant-based diet provided a significant reduction in LDL, as well as reductions in fasting insulin and weight compared with a healthy omnivore diet, in an 8-week controlled twin trial.

A recent scientific review confirms that artificial sweeteners affect primary cardiovascular risk factors.

Cholesterol deposits over the eyelids were not associated with an increased prevalence of lipid abnormalities or cardiovascular risk in a new study.

The European Union's drug regulator will this week consider wider use of Novo Nordisk's weight-loss drug Wegovy to include reducing the risk of strokes and heart...

The GLP-1 agonist has shown convincing benefits in yet another population, patients with peripheral arterial disease, in a practice-changing trial, according to experts.

Bempedoic acid and bempedoic–ezetimibe are now indicated to prevent myocardial infarction and cardiovascular procedures in both primary- and secondary-prevention patients regardless of statin use.

Around 800,000 deaths annually in Europe were due to air pollution, about half of which were due to cardiovascular diseases, said experts.

The mother's COX1 genotype could influence whether prenatal fish oil supplementation affects the risk for atopic dermatitis in children, a study found.

Patients with primary Sjögren disease with organ involvement were at a high risk for subclinical atherosclerosis, a study suggested.

Research builds on growing evidence that the sweetener erythritol may not be safer than sugar after all.

The findings strengthen the case for initial CAC imaging as a gatekeeper to further testing in some primary-prevention patients with ASCVD risk factors, researchers say.

Two years after percutaneous coronary intervention, people at risk of a cardiac event had better outcomes with clopidogrel maintenance therapy than with aspirin in the SMART-CHOICE 3 trial.

People who primarily sit during the workday face a 34% increased risk of dying of heart disease compared with workers who largely don't sit, but taking breaks and engaging in leisure-time activity attenuates the risk.

The hepatocyte-targeted small interfering RNA lowers triglyceride and other lipoprotein levels, and even reduces liver fat, report trial investigators.

New bempedoic acid and bempedoic acid/ezetimibe labels add primary hyperlipidemia and remove the maximally tolerated statin requirement and statement on the effect on mortality.

Cross-sectional study with a diverse cohort revealed no effect modification associated with Hispanic ethnicity.

An occult voice 'biomarker' predicted CV-event risk in an angiography-referral cohort, with implications for screening, noninvasive risk stratification, and telemedicine, researchers say.

Clinicians need to pay more attention to nontraditional stroke risk factors, especially in adults under 35 years, new research suggests.